Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2007) 13 P13a

SFEBES2007 Poster Presentations Diabetes, metabolism and cardiovascular (63 abstracts)

Proactive care planning in diabetes: The benefit of enhanced primary and secondary care interaction

Trudi Martin 1 , Jane Smithson 2 , Lesley Thompson 1 , Lindsey Oliver 1 , Angela Walker 1 , Charles Dean 3 & David Woods 1


1Northumbria Diabetes Service; 2Practice Nurse, Wellclose Square Surgery, Berwick-upon-Tweed, Northumberland, UK; 3GP, Burnhouse Road, Wooler, Northumberland.


Background: It is well established that diabetes-related complications are greatest in patients with a high HbA1c and in those who do not attend primary or secondary care clinics. For an equivalent reduction in HbA1c greater benefits are achieved in those with a high baseline.

Aim: To determine if a simple action plan implemented by the Diabetes and Practice Nurse in primary care could improve glycaemic control.

Methods: A primary care surgery in North Northumberland was approached. The Diabetes and Practice nurses reviewed the computerised records of all patients registered at the surgery with an HbA1c≥7.5%. An action plan was constructed and instigated. 12 patients were referred to secondary care, 11 patients attended a dietician-led community pre-insulin assessment (5 of which were subsequently commenced on insulin), 9 were found to be house-bound and were visited at home. The remainder had a simple stepped-approach to increase oral hypoglycaemic therapy. HbA1c results were reviewed 6 months later.

Results: 481 patients with diabetes were identified. 107 patients (22.3%) had an HbA1c≥7.5% (mean 9.0+/−1.6); 26 (24%) of these had an HbA1c ≥10% (the “high HbA1c group”, mean 11.2+/−1.4). 80 of the 91 patients with follow-up data had an improved HbA1c. Mean HbA1c in the whole cohort was 8.1+/−1.7 (P<0.001 by ANOVA for change from baseline), and in the high-HbA1c group mean HbA1c was 9.4+/−2.4 (P<0.001 by ANOVA for change from baseline).

Conclusion: Simple, brief, inexpensive interventions and close liaison with primary care can lead to significant improvements in HbA1c. In the high HbA1c group a mean reduction of 1.8% is much better than that achieved in pharmaceutical trials of new therapeutic agents and is likely to have a major impact on complication rates. Such an approach is advantageous to the patient, secondary care and not least primary care in view of the new GMS contract.

Article tools

My recent searches

No recent searches.